1. Home
  2. ABVX vs LE Comparison

ABVX vs LE Comparison

Compare ABVX & LE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVX
  • LE
  • Stock Information
  • Founded
  • ABVX 2013
  • LE 1963
  • Country
  • ABVX France
  • LE United States
  • Employees
  • ABVX N/A
  • LE N/A
  • Industry
  • ABVX
  • LE Clothing/Shoe/Accessory Stores
  • Sector
  • ABVX
  • LE Consumer Discretionary
  • Exchange
  • ABVX Nasdaq
  • LE Nasdaq
  • Market Cap
  • ABVX 407.6M
  • LE 323.8M
  • IPO Year
  • ABVX N/A
  • LE N/A
  • Fundamental
  • Price
  • ABVX $6.25
  • LE $10.18
  • Analyst Decision
  • ABVX Buy
  • LE Strong Buy
  • Analyst Count
  • ABVX 8
  • LE 2
  • Target Price
  • ABVX $34.63
  • LE $20.00
  • AVG Volume (30 Days)
  • ABVX 317.1K
  • LE 140.4K
  • Earning Date
  • ABVX 03-24-2025
  • LE 03-20-2025
  • Dividend Yield
  • ABVX N/A
  • LE N/A
  • EPS Growth
  • ABVX N/A
  • LE N/A
  • EPS
  • ABVX N/A
  • LE 0.20
  • Revenue
  • ABVX $11,172,999.00
  • LE $1,362,935,000.00
  • Revenue This Year
  • ABVX $306.91
  • LE $6.31
  • Revenue Next Year
  • ABVX N/A
  • LE N/A
  • P/E Ratio
  • ABVX N/A
  • LE $51.55
  • Revenue Growth
  • ABVX 135.94
  • LE N/A
  • 52 Week Low
  • ABVX $5.50
  • LE $9.91
  • 52 Week High
  • ABVX $16.63
  • LE $19.88
  • Technical
  • Relative Strength Index (RSI)
  • ABVX 40.22
  • LE 41.12
  • Support Level
  • ABVX $5.60
  • LE $10.08
  • Resistance Level
  • ABVX $7.85
  • LE $11.05
  • Average True Range (ATR)
  • ABVX 0.60
  • LE 0.56
  • MACD
  • ABVX -0.05
  • LE -0.02
  • Stochastic Oscillator
  • ABVX 28.89
  • LE 17.20

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

About LE Lands' End Inc.

Lands' End Inc is a United States-based multi-channel retailer of casual clothing, accessories, and footwear, as well as home products. The company's operating segment includes U.S. eCommerce; International; Outfitters; Third Party and Retail. It generates maximum revenue from the U.S. eCommerce segment. The U.S. eCommerce segment offers products through the company's eCommerce website. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: